[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Impact Factor 2022: 1.4
Cite Score 2022: 2.1
SJR 2022: 0.347
SNIP 2022: 0.545
..
Publication Charge
►Publication Fee
..
In Press
 In Press Articles
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 11, Issue 3 (5-2020) ::
Caspian J Intern Med 2020, 11(3): 337-339 Back to browse issues page
Mucinous Eccrine Carcinoma of the Eyelid: A Case Report Study
Etrat Javadirad , Javad Azimivaghar , Saba Montazer
Department of Cardiology, School of Medicene, Kermanshah University of Medical Sciences, Kermanshah, Iran , drjavadirad.e@gmail.com
Abstract:   (3217 Views)
Background: Primary mucinous eccrine carcinoma (PMEC) is a quite rare malignant tumor that typically involves the head and neck region in approximately 75% of patients and the periorbital area is the most common area.
Case Presentation: A 57-year-old man was seen with a painless red mass involving the left lower eyelid for the past 7 months. Examination revealed a small mass measuring 0.6 cm with shiny red smooth appearance of the skin. H&E stained examination revealed a tumor mass that composed of polygonal cells in nests, lobules and islands separated by large amount of mucin. The neoplastic cells showed eosinophilic cytoplasm and round nuclei with mild pleomorphism. There was no necrosis, no atypical mitosis, no lymphovascular and perineural invasion. Rare mitotic figures were found. Tumoral nests present on all surgical margins. Primary MEC is a slow-growing neoplasm that may recur after incomplete surgical excision. This tumor is often clinically mistaken for other cutaneous tumors due to its variable appearance. Recurrent tumor tends to be locally invasive with a rare metastatic rate of 9.6%.
Conclusion: As a result of the recurrence risk, patients should be followed up regularly. Thus, our patient was recommended to have a regular follow-up every six months.
Keywords: Eccrine, Mucinous, carcinoma, Eye
Full-Text [PDF 194 kb]   (801 Downloads)    
Type of Study: case report | Subject: Pathology
Received: 2019/03/2 | Accepted: 2019/09/4 | Published: 2020/05/21
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Javadirad E, Azimivaghar J, Montazer S. Mucinous Eccrine Carcinoma of the Eyelid: A Case Report Study. Caspian J Intern Med 2020; 11 (3) :337-339
URL: http://caspjim.com/article-1-1794-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 11, Issue 3 (5-2020) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.06 seconds with 40 queries by YEKTAWEB 4645